Drug intelligence / Profile preview

lauric acid

Development stage
Preclinical
Lead developer
Synergy Pharmaceuticals
Modality
Small Molecules
Administration
Oral, Intratumoral, Intraduodenal
01

Overview

Lauric acid is a medium-chain saturated fatty acid (C12:0) naturally abundant in coconut and palm kernel oils, investigated for its diverse therapeutic potential in oncology, infectious disease, and metabolic disorders. In head and neck squamous cell carcinoma (HNSCC), it has been developed as a thermosensitive injectable depot for the sustained local delivery of chemotherapeutics, while also demonstrating intrinsic antitumor activity. As an antimicrobial agent, it is being evaluated in clinical trials (under the code GT08) for the treatment of Helicobacter pylori infection and as a supplement to reduce systemic inflammation and the viral reservoir in patients with HIV. Mechanistically, lauric acid acts as an agonist for GPR84 and Toll-like receptors (TLR2, TLR4), and serves as a metabolic precursor to dilauroylphosphatidylcholine (DLPC), which activates the nuclear receptor LRH-1 (NR5A2) to provide hepatoprotective effects in inflammatory cholangiopathies. It also modulates fibrotic progression in inflammatory bowel disease through PPARγ activation.

Other names
dodecanoic acidC12C-12C 12C12:0
02

Targets

NR5A2 (Purinergic receptor P2X5)TLR4 (Toll-like receptor 4)PPARG (Peroxisome proliferator-activated receptor gamma)GPR84TLR2 (Toll-like Receptor 2)

Beyond the preview

Go deeper on lauric acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lauric acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call